Medicare Enrolled

Dr. Bassem Chahine, M.D.

Allergy & Immunology · Miami, FL
8740 N KENDALL DR, Miami, FL 33176
3052701073
Registered in NPPES since 2006
NPI: 1518971753 verify on NPPES ↗
High
DATA COVERAGE
Data in 3 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Chahine from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Chahine? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Chahine

Dr. Bassem Chahine is an allergy & immunology specialist in Miami, FL, with 20 years of NPI registration.

Between the years covered by Open Payments, Dr. Chahine received a total of $7,083 from 31 pharmaceutical and/or device companies across 226 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Chahine is High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 20 years of NPI registration $7,083 industry payments

Florida License Status

FL DOH · MQA
1
Active license
None
Board action on record
0
Recent admin complaints
Profession License # Status Expires Board Action
Medical Doctor 98543 Clear January 31, 2027
Data from Florida Department of Health Medical Quality Assurance. License records are public under Chapter 119, Florida Statutes. Verify directly on FL DOH →

Industry Payment Transparency

Open Payments through 2024 ↗
$7,083
Total received (2018-2024)
Avg $1,012/year across 7 years
Top 40% in FL for allergy & immunology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
31
Companies
226
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →

Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$1,940
2023
$1,321
2022
$1,383
2021
$579
2020
$125
2019
$699
2018
$1,037

Payments by company (2024)

Takeda Pharmaceuticals U.S.A., Inc.
$356
Incyte Corporation
$217
GENZYME CORPORATION
$207
GlaxoSmithKline, LLC.
$187
ADMA BioManufacturing LLC
$150
Regeneron Healthcare Solutions, Inc.
$132
Hikma Pharmaceuticals USA
$118
PFIZER INC.
$108
ALK-Abello, Inc
$96
Novartis Pharmaceuticals Corporation
$78
Genentech USA, Inc.
$77
AstraZeneca Pharmaceuticals LP
$75
ABBVIE INC.
$49
Optinose US, Inc.
$24
Octapharma USA, Inc.
$20
TerSera Therapeutics LLC
$19
Blueprint Medicines Corporation
$15
Grifols USA, LLC
$13
Top 3 companies account for 40.2% of 2024 payments
All-time payments by company (2018-2024) ›
GlaxoSmithKline, LLC.
$1,401
PFIZER INC.
$796
Takeda Pharmaceuticals U.S.A., Inc.
$563
GENZYME CORPORATION
$547
Regeneron Healthcare Solutions, Inc.
$525
AstraZeneca Pharmaceuticals LP
$452
ALK-Abello, Inc
$410
ADMA BioManufacturing LLC
$323
Incyte Corporation
$307
Genentech USA, Inc.
$269
Blueprint Medicines Corporation
$221
Hikma Pharmaceuticals USA
$163
OptiNose US, Inc.
$151
Novartis Pharmaceuticals Corporation
$135
Kaleo, Inc.
$125
Amgen Inc.
$120
Teva Pharmaceuticals USA, Inc.
$82
AIMMUNE THERAPEUTICS, INC.
$74
Optinose US, Inc.
$67
Shire North American Group Inc
$58
AbbVie Inc.
$49
ABBVIE INC.
$49
CSL Behring
$30
LEO Pharma Inc.
$28
Pharming Healthcare, Inc.
$27
Aimmune Therapeutics, Inc.
$24
Boston Scientific Corporation
$21
Octapharma USA, Inc.
$20
TerSera Therapeutics LLC
$19
Exeltis, USA Inc.
$14
Grifols USA, LLC
$13
Top 3 companies account for 39.0% of all-time payments
Associated products mentioned in payments ›
ADBRY · AIRSUPRA · AJOVY · AYVAKIT · Auvi-Q · CIBINQO · CINQAIR · CUVITRU · DERMATITIS - DISEASE · DUPIXENT · DUPIXENT DUPILUMAB INJECTION · EUCRISA · FASENRA · General - Pain Management · HYQVIA · Haegarda · NUCALA · Neosalus · OCTAGAM IMMUNE GLOBULIN (HUMAN) · OPZELURA · Odactra · PALFORZIA · PANZYGA · QVAR · Quzyttir · RINVOQ · RUCONEST · Ragwitek · Ryaltris · TAKHZYRO · TEZSPIRE · TRELEGY ELLIPTA · XOLAIR · Xembify · Xhance · Xolair
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Looking for an allergy & immunology specialist in Miami?
Compare allergy & immunologists in the Miami area by procedure volume, costs, and industry payment transparency.
Browse allergy & immunologists nearby

Geographic Context

Allergy & immunologists in nearby ZIP areas
33
County median income
$68,694
Nearest hospital to ZIP centroid (approximate)
BAPTIST HOSPITAL OF MIAMI
0.0 mi

Data Sources

Provider Registry NPPES NPPES snapshot; verify current record
Medicare Enrollment PECOS PECOS snapshot
Practice Data — No data N/A
Industry Payments Open Payments CY 2024
Disciplinary History — Not included N/A

This provider has data in 3 of 4 available federal datasets, with a Data Coverage level of High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Chahine is an allergy & immunology specialist, with 20 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Does Dr. Chahine receive payments from pharmaceutical companies?
Yes. Dr. Chahine received a total of $7,083 from 31 companies across 226 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
What does Data Coverage mean?
Data Coverage (currently High for Dr. Chahine) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
About this page

This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Industry payment disclosure alone establishes neither wrongdoing nor legality. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →